Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma

International Journal of Hematology

Volumn 92, Issue 1, 2010, Pages 83-94

  Wang, Suyun ^a,b   Cheng, Zhiyong ^a   Yang, Xiaoyang ^a,c   Deng, Kai ^a   Cao, Yan ^a   Chen, Hao ^a   Pan, Ling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

^c HAIKOU PEOPLE S HOSPITAL   (China)

Author keywords

FAK; Invasion; MMP; Multiple myeloma; PTEN

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PTEN GENE; SURVIVAL RATE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE THERAPY; HUMANS; MULTIPLE MYELOMA; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; TREATMENT OUTCOME;

EID: 77955175183     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0604-y     Document Type: Article

References (39)

1. RA Kyle SV Rajkumar 2008 Multiple myeloma Blood 111 6 2962 2972 10.1182/blood-2007-10-078022 1:CAS:528:DC%2BD1cXjvVamt7w%3D 18332230
2. M Strobeck 2007 Multiple myeloma therapies Nat Rev Drug Discov 6 3 181 182 10.1038/nrd2269 1:CAS:528:DC%2BD2sXit12rtro%3D 17396289
3. YW Qiang K Walsh L Yao, et al. 2005 Wnts induce migration and invasion of myeloma plasma cells Blood 106 5 1786 1793 10.1182/blood-2005-01-0049 1:CAS:528:DC%2BD2MXps1Ogt78%3D 15886323
4. H Bao M Jiang M Zhu F Sheng J Ruan C Ruan 2009 Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma Int J Hematol 90 2 177 185 10.1007/s12185-009-0356-8 1:CAS:528:DC%2BD1MXhtVeitbvI 19585213
5. V Ullmannova-Benson M Guan X Zhou, et al. 2009 DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway Leukemia 23 2 383 390 10.1038/leu.2008.285 1:CAS:528: DC%2BD1MXhs1Ols78%3D 18923442
6. H Chang XY Qi J Claudio L Zhuang B Patterson AK Stewart 2006 Analysis of PTEN deletions and mutations in multiple myeloma Leuk Res 30 3 262 265 10.1016/j.leukres.2005.07.008 1:CAS:528:DC%2BD28XksFGiuw%3D%3D 16112193
7. J Li C Yen D Liaw, et al. 1997 PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 5308 1943 1947 10.1126/science.275.5308.1943 1:CAS:528:DyaK2sXit1Wgtbk%3D 9072974
8. Y Tang C Eng 2006 PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner Cancer Res 66 2 736 742 10.1158/0008-5472.CAN-05-1557 1:CAS:528:DC%2BD28XlsFOksQ%3D%3D 16424003
9. NL Ge S Rudikoff 2000 Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo Oncogene 19 36 4091 4095 10.1038/sj.onc.1203801 1:CAS:528:DC%2BD3cXmsVKls7c%3D 10962569
10. A Aggerholm K Gronbaek P Guldberg P Hokland 2000 Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders Eur J Haematol 65 2 109 113 10.1034/j.1600-0609.2000.90181.x 1:CAS:528: DC%2BD3cXlvFynu7c%3D 10966170
11. A Suzuki JL de la Pompa V Stambolic, et al. 1998 High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice Curr Biol 8 21 1169 1178 10.1016/S0960-9822(07) 00488-5 1:CAS:528:DyaK1cXntFWgsb8%3D 9799734
12. YL Liu RP Castleberry PD Emanuel 2009 PTEN deficiency is a common defect in juvenile myelomonocytic leukemia Leuk Res 33 5 671 677 10.1016/j.leukres. 2008.09.036 1:CAS:528:DC%2BD1MXivVWqu7c%3D 19010541
13. YC Yang TC Ho SL Chen HY Lai JY Wu YP Tsao 2007 Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line BMC Cancer 7 216 10.1186/1471-2407-7-216 18021457
14. DD Schlaepfer CR Hauck DJ Sieg 1999 Signaling through focal adhesion kinase Prog Biophys Mol Biol 71 3-4 435 478 10.1016/S0079-6107(98)00052-2 1:CAS:528:DyaK1MXislaqtbw%3D 10354709
15. M Canel P Secades M Garzón-Arango, et al. 2008 Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression Br J Cancer 98 7 1274 1284 10.1038/sj.bjc.6604286 1:CAS:528:DC%2BD1cXktVKhsrg%3D 18349846
16. CR Hauck DJ Sieg DA Hsia, et al. 2001 Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells Cancer Res 61 19 7079 7090 1:CAS:528:DC%2BD3MXnsVehs7k%3D 11585739
17. Y Zhang AA Thant Y Hiraiwa, et al. 2002 A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90 Biochem Biophys Res Commun 290 3 1123 1127 10.1006/bbrc.2001.6321 1:CAS:528:DC%2BD38XksV2itw%3D%3D 11798192
18. B Hu MJ Jarzynka P Guo Y Imanishi DD Schlaepfer SY Cheng 2006 Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway Cancer Res 66 2 775 783 10.1158/0008-5472.CAN-05-1149 1:CAS:528:DC%2BD28XlsFOkuw%3D%3D 16424009
19. A Smith F Wisloff D Samson 2006 Guidelines on the diagnosis and management of multiple myeloma 2005 Br J Haematol 132 4 410 451 10.1111/j.1365-2141.2005.05867.x 16412016
20. ZY Cheng XL Guo SH Li, et al. 2009 The role of PTEN-FAK signaling pathway in metastasis and invasive ability of leukemia cells Zhonghua Xue Ye Xue Za Zhi 30 2 115 120 1:CAS:528:DC%2BD1MXhsVWisbfO 19563023
21. L Kotelevets J van Hengel E Bruyneel M Mareel F van Roy E Chastre 2001 The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness J Cell Biol 155 7 1129 1135 10.1083/jcb.200105109 1:CAS:528:DC%2BD38XhslyhsA%3D%3D 11756467
22. R García-Sanz A Orfão M González, et al. 1999 Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics Blood 93 3 1032 1037 9920853
23. JE Guikema E Vellenga WH Abdulahad S Hovenga NA Bos 2004 CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinases Br J Haematol 124 3 299 308 10.1046/j.1365-2141.2003.04783.x 1:CAS:528:DC%2BD2cXhs1Gnsb0%3D 14717776
24. AB Fassas T Spencer J Sawyer, et al. 2002 Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma Br J Haematol 118 4 1041 1047 10.1046/j.1365-2141.2002.03757.x 1:CAS:528: DC%2BD38Xotlanurk%3D 12199783
25. J Zhang JC Grindley T Yin, et al. 2006 PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention Nature 441 7092 518 522 10.1038/nature04747 1:CAS:528:DC%2BD28XkvVyku74%3D 16633340
26. F Pene YE Claessens O Muller, et al. 2002 Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma Oncogene 21 43 6587 6597 10.1038/sj.onc.1205923 1:CAS:528:DC%2BD38XntFemsrw%3D 12242656
27. Y Shi J Gera L Hu, et al. 2002 Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779 Cancer Res 62 5027 5034 1:CAS:528:DC%2BD38Xmslyksrk%3D 12208757
28. AI Jacob T Romigh KA Waite C Eng 2009 Nuclear PTEN levels and G2 progression in melanoma cells Melanoma Res 19 4 203 210 10.1097/CMR. 0b013e32832ccd6e 1:CAS:528:DC%2BD1MXos1entL8%3D 19478684
29. JH Chung MC Ostrowski T Romigh T Minaguchi KA Waite C Eng 2006 The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation Hum Mol Genet 15 17 2553 2559 10.1093/hmg/ddl177 1:CAS:528:DC%2BD28XotlaisLs%3D 16849370
30. K Uegaki Y Kanamori J Kigawa, et al. 2006 PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells Cell Tissue Res 323 3 523 528 10.1007/s00441-005-0082-3 1:CAS:528:DC%2BD28Xhtlegtro%3D 16283392
31. M Tamura J Gu T Takino KM Yamada 1999 Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas Cancer Res 59 2 442 449 1:CAS:528: DyaK1MXntFOjuw%3D%3D 9927060
32. MH Oktay K Oktay D Hamele-Bena A Buyuk LG Koss 2003 Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas Hum Pathol 34 3 240 245 10.1053/hupa.2003.40 1:CAS:528:DC%2BD3sXisleit78%3D 12673558
33. LJ Kornberg 1998 Focal adhesion kinase and its potential involvement in tumor invasion and metastasis Head Neck 20 8 745 752 10.1002/(SICI)1097- 0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z 1:STN:280: DyaK1M%2FgsV2mug%3D%3D 9790298
34. DD Schlaepfer SK Mitra 2004 Multiple connections link FAK to cell motility and invasion Curr Opin Genet Dev 14 1 92 101 10.1016/j.gde.2003.12.002 1:CAS:528:DC%2BD2cXps1yktg%3D%3D 15108811
35. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 3 161 174 10.1038/nrc745 1:CAS:528:DC%2BD38Xis1KktL8%3D 11990853
36. E Van Valckenborgh PI Croucher H De Raeve, et al. 2004 Multifunctional role of matrix metalloproteinases in multiple myeloma Am J Pathol 165 3 869 878 15331411
37. T Kelly M Børset E Abe D Gaddy-Kurten RD Sanderson 2000 Matrix metalloproteinases in multiple myeloma Leuk Lymphoma 37 3-4 273 281 1:CAS:528:DC%2BD3MXovVyr 10752979
38. A Vacca D Ribatti AM Roccaro A Frigeri F Dammacco 2001 Bone marrow angiogenesis in patients with active multiple myeloma Semin Oncol 28 6 543 550 10.1016/S0093-7754(01)90022-3 1:STN:280:DC%2BD3MnptlOnsg%3D%3D 11740807
39. Y Hu CY Sun J Huang L Hong L Zhang ZB Chu 2007 Antimyeloma effects of resveratrol through inhibition of angiogenesis Chin Med J 120 19 1672 1677 1:CAS:528:DC%2BD2sXhtlOiurzM 17935668